Genetic analysis of hypertension has yielded inconsistent results, making it difficult to draw clear conclusions regarding the impact of specific variants on blood pressure regulation. Among the most studied of the candidate genes for blood pressure regulation is angiotensinogen (AGT), but as with other candidate loci associations with blood pressure have been inconsistent. We examined the contributions of two AGT polymorphisms (T174M and M235T) to detect the effects of each on blood pressure variation, using single-site and two-site analyses. We analysed data from a study of 177 subjects from Accra, Ghana. We observed significant single-locus associations of the T174M polymorphism with average systolic (SBP) and diastolic blood pressure (DBP) when age was used as a covariate (Po0.001 and P ¼ 0.010, respectively). Also, we observed a significant association of the M235T polymorphism with SBPs and DBPs (Po0.001 and P ¼ 0.014, respectively). Finally, we observed a simultaneous significant association of the two polymorphisms with SBP and DBP (Po0.001 and P ¼ 0.026, respectively), although the two-loci model is not significantly better than either single-locus model. However, for SBP the two-loci model is marginally better (P ¼ 0.08 in comparison to both single-locus models). These results suggest that variants at these two AGT sites together, in conjunction with age, may be significantly associated with elevated SBP, whereas the single-site models are as good models of DBP. It is possible that earlier inconsistent results with these AGT polymorphisms with hypertension in African-derived populations may have resulted from an 'incomplete' model in the different study populations. Given the inconclusive nature of our two-loci results, this possibility requires further investigation.
Introduction
Many genes have the potential to regulate blood pressure, 1 but there have been few genes that have consistently associated with blood pressure variation across studies. 2, 3 One of the most reproducible findings is that variations in the angiotensinogen (AGT) gene associate with hypertension, 4-6 although negative results for specific polymorphisms are also common. 3, 7 Additionally, AGT variants have been shown to associate with serum AGT in black and white children, providing a potential mechanism for genetic associations. 8 In a recent report, we examined association between two variations in the AGT gene (M235T and T174M) and hypertension, and failed to showed a single-locus association. 9 This finding is based on the qualitative assignment of individuals into either normotensive or hypertensive categories and for association with only one site at a time. In the present study, using a different analytical approach, we examine the contributions of variations in these two AGT polymorphisms, to assess their association with quantitative variation in blood pressure in the same Ghanaian subjects. This parametric approach assessed monogenic and polygenic effects, in conjunction with the age of the subjects, and provides a more powerful means to assess the role of AGT variation in blood pressure regulation.
Our results show that both single-locus and twoloci models, in conjunction with age, are significant predictors of both systolic (SBP) and diastolic blood pressure (DBP). From these results, we hypothesize that these two SNPs or variants in linkage disequilibrium with at least one of them, in conjunction with age, associate with elevated blood pressure and most likely risk of hypertension, despite the lack of significant association in our earlier analyses. 9 It is also possible that two-loci models are better predictors of SBP but not DBP; however, our findings yield only marginal significance and it is, therefore, necessary to evaluate this possibility in other studies.
Materials and methods

Subjects and genotyping
Genomic DNA samples were obtained from 177 unrelated individuals who were measured for blood pressure and genotyped for previously identified variants in the AGT gene. 9 Subject recruitment, demographic information, and genotyping protocols have been described in detail elsewhere. 9 Briefly, blood pressures were taken twice on each subject and the mean value was used as the final quantitative measure. Omron-automated blood pressure monitors (Models 712c or 713c) were used, which have been shown to provide accurate and reproducible measurements and use a protocol similar to the Omron 705CP, which has been validated by the British Hypertension Society. 10, 11 To ensure consistency, manual readings were also taken on several of the individuals.
Statistical analysis
Genetic analysis of the associations of the AGT polymorphisms with blood pressures were performed using the General Linear Model module of the statistical analysis software package SPSS for Windows. The model for this statistical analysis was as follows, the AGT polymorphisms were the 'independent' variables, blood pressure measurements were the 'dependent' variables, and age was assigned as the 'covariate'. We tested to determine whether the model with both SNPs was significantly better than models using only a single SNP with an F-test where:
and RSS is the residual sum of squares of the singlelocus model, RSS H the sum of square of the full model, q the degrees of freedom of the full, two-loci, model minus degrees of freedom of the restricted, single SNP model, p the degrees of freedom of the full model, n the sample size. 12 Haplotypes were estimated using the Ehplus software. 13 
Results
The association of the T174M polymorphism with SBP and DBP is seen in Table 1 . In the model, with age as a covariate, there are significant differences in mean blood pressures between genotypes. The presence of the 174M allele is associated with an increase in both SBP (Po0.001) and DBP (P ¼ 0.010). In addition, age is significantly associated with blood pressure.
Analysis of the M235T polymorphisms revealed effects similar to those for T174M ( Table 2) . As with the AGT T174M association model, age was used as a covariate, and significant differences in mean blood pressures were observed. The 235T allele associated with elevated SBPs and the M235 allele was associated with elevated DBPs. The level of significance for SBPs and DBPs were Po0.001 and P ¼ 0.014, respectively. Although it is often the case that blood pressure varies with gender, in our cohort neither SBP nor DBP differed between genders when analysed with age as a covariate (analyses not shown).
The results of the simultaneous analysis of the T174M and M235T polymorphisms with SBP and DBP, with age as a covariate, show that those individuals heterozygous for T174M and homozygous for the 235T polymorphism have significantly higher SBPs and DBPs (Table 3 ). The level of statistical significance for SBPs and DBPs are Po0.001 and P ¼ 0.026, respectively. However, the two-loci model is not a significantly better predictor of SBP than either single-locus model with F 1,150 ¼ 3.05 (P ¼ 0.08) or F 1,150 ¼ 3.06 (P ¼ 0.08) for T174M and M235T, respectively. However, it is close to significance in both cases. For DBP, there is no improvement found by using a two-loci model. For T174M F ¼ 0.57 (P ¼ 0.45) and for M235T F ¼ 0.94 (P ¼ 0.33).
The haplotype analysis shows that alleles at these two polymorphisms are in equilibrium with each other (P ¼ 0.43) (Table 4) . Therefore, the associations with each site independently do not appear to result from the effects of linkage disequilibrium between the two variable sites within the AGT gene, but from the individual effects of the two variants or other unmeasured variants. It is important to note that the borderline effects of the two-loci model may be the 
Discussion
In humans, several polymorphisms in the AGT gene have been associated with hypertension, 5,6,14 but none of the identified polymorphisms associate in all populations studied. 3 Rotimi et al 15 investigated polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African-Americans. The insertion/deletion (I/D) polymorphism of the AGTconverting enzyme (ACE) and the AGT M235T and AGT T174M variants of the AGT gene were examined and, despite large differences in hypertension rates, genetic differences at these loci were modest among these groups. Other studies of AGT variants have also failed to show association with either hypertension or blood pressure. A community survey in Jamaica found only weak evidence for a relationship between circulating angiotensin level and blood pressure. 16 The molecular markers examined in this study did not confer risk of hypertension or higher levels of AGT for the group as a whole, although a trend was apparent in subanalyses for each gender separately. In an investigation In another study of essential hypertension, Caulfield et al 19 tested whether there is linkage of the AGT gene to hypertension risk in an Afro-Caribbean cohort from St. Vincent and the Grenadines. In their sibpair analysis, there was significant linkage and association of this locus to hypertension. However, when they assessed the AGT M235T polymorphism, they found no association of this variant with hypertension. These findings provide support for linkage and association of the AGT locus to hypertension in Afro-Caribbeans, but not for the one particular SNP that we studied.
Our analyses reveal that in a data set previously showing no association with hypertension as a phenotype, a parametric analysis, using age as a covariate, reveals a significant association with two AGT polymorphisms, M235T and T174M. These two genetic polymorphisms are in linkage disequilibrium (LD) in some of the populations previously studied, 20, 21 leading to the previous suggestion that only one of them is truly associating with hypertension and the second only because of LD between the two sites. However, in our population, there is no evidence of LD, making the observation of significant effects of each polymorphism more compelling, and the two-site model suggestive of multiple changes in the AGT gene being important in the regulation of blood pressure.
The failure to detect an association with hypertension as a clinical end point, while finding significance with blood pressure, may be caused by several factors. First is the possibility of increased power of parametric analyses as compared to nonparametric analyses. In addition, in the present analysis, we incorporated the effects of age, which we did not do in our earlier study. Second, it is possible that the impact of the effect, although significant, may not be strong enough to explain the hypertensive/normotensive cutoff level. Third, some have suggested that polygenic effects, or the construction of a haplotype composed of various AGT loci, are significantly associated with hypertension risk. 2, 22 If this were the case, the genetic background may modify the effect of specific polymorphisms on the defined clinical phenotype; therefore, variation may be physiologically important but will not necessarily affect quantitative variation in blood pressure because the variants' effects are masked. Unfortunately, our results are unclear on this point. The SBP data are only suggestive regarding the possibility that the full, two-loci model is better than either single-locus model. Testing the generality of this possibility will require that studies be undertaken in other populations with larger sample sizes. These kinds of multilocus effects would be consistent with the complex inheritance of hypertension. Therefore, despite the limitations of our findings with respect to this point, we suggest that inconsistent results from previous association studies of AGT polymorphisms may result from an 'incomplete' model in the different study populations.
